DESIGN AND CHARACTERIZATION OF AMOXICILLIN TRIHYDRATE MUCOADHESIVE MICROSPHERES FOR PROLONGED GASTRIC RETENTION
Abstract
Whilst there is keen interest in developing improved drug delivery systems to gastro intestinal tract for treatment of Helicobacter pylori induced peptic and duodenal ulcers, In an effort to augment the anti-Helicobacter pylori effect of Amoxicillin trihydrate mucoadhesive microspheres, which have the ability to reside in the gastrointestinal tract for an extended period, were prepared with ethyl cellulose as a matrix and carbopol 934P as a mucoadhesive polymer. Particle size was determined by optical micrometer and average particle size was found in the range of 500-560 m for all batches. All the batches showed good in vitro mucoadhesive property. Cumulative percent drug release was found to be maximum for FI (91.12 %). Formulation FII found to follow Higuchi matrix with the regression value of 0.9985. Form the all batches FI formulated microspheres showed more mucoadhesive property due to less amount of ethyl cellulose. In conclusion, the prolonged gastrointestinal residence time and controlled release might make contribution to H. Pylori clearance.
Keywords:
Amoxicillin trihydrate, Carbopol 934P, H. pylori, Mucoadhesive microspheresDOI
https://doi.org/10.25004/IJPSDR.2010.020205References
Vasir JK, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm. 2003; 255: 13-32.
Rao SB, Sharma CP. Use of chitosan as biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res. 1997; 34: 21-28.
Helicobacter pylori infection. http://www.patient.co.uk/printer/asp?doc=2306875. Accessed 22 Sep2006.
Linda NM, Douglas JB. Management of Helicobacter pylori infection. American family physician. 2002; 65(7): 1327-1339.
Paul H, Barbara W, Veronique H, Stefan B, Patrick B, Manfred K. Pathologenesis of Helicobacter Pylori infection Helicobacter. 2004; 9: 15-22.
Erah PO, Goddard AF, Baerret DA, Shaw PN, Spiller RC. The stability of Amoxicillin, Clarithromycin and Metronidazole in gastric juice: Relevance to the treatment of Helicobacter pylori infection. 1997; 37: 5-12.
British Pharmacopoeia. London: Stationary office. 2001; Vol. I: 1340-1342.
Martindale. The complete drug reference. 32nd ed. Pharmaceutical Press, 1999; pp. 190-191.
Zhepeng L, Weiyue L, Lisheng Q, Xuhui Z, Pengyun Z, Jun P. In vitro and in vivo studies on mucoadhesive microspheres of Amoxicillin. J Cont Rel. 2005; 102: 135-44.
Shirur M, Chen J, Wei Z, Liu H, Bi D. Intranasal administration of melatonin starch microspheres. Int J Pharm Sci. 2004; 272: 37-43.
Huang YC, Yen MK, Chiang CH. Formulation factors in preparing BTM-Chitosan microspheres by spray drying method. Int J Pharm. 2000; 242: 239-42.
Lynne W, John HC, John TF. Amoxicillin release from a floating dosage from based on alginates. Int J Pharm. 2000; 210: 45-9.
Jain KS, Awasthi AM, Jain NK, Agrawal GP. Calcium silicate based microspheres of Repaglinide for gastroretentive floating drug delivery: Preparation and in vitro characterization. J Con Rel. 2005; 107: 300-9.
Ranga KV, Buri P. A novel in situ method to test polymer and coated microparticles for bioadhesion. Int J Pharm. 1989; 52.
Akiyama Y, Nagahara N, Kashihara T, Hirai S, Toguchi H. In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acids and a poly (acrylic acid) derivative. Pharm Res. 1995; 12(3): 397-405.
Published


How to Cite
Issue
Section
Copyright (c) 2010 Shiva Kumar Yellanki, Jeet Singh, Jawad Ali Syed, Rajkamal Bigala, Sharada Goranti, Naveen Kumar Nerella

This work is licensed under a Creative Commons Attribution 4.0 International License.